Federal Register / Vol. 89, No. 35 / Wednesday, February 21, 2024 / Notices 13087 

approved collection; Title of 

Information Collection: Administrative 

Requirements for Section 6071 of the 

Deficit Reduction Act; Use: State 

Operational Protocols should provide 

enough information such that: the CMS 

Project Officer and other federal officials 

may use it to understand the operation 

of the demonstration, prepare for 

potential site visits without needing 

additional information, or both; the 

State Project Director can use it as the 

manual for program implementation; 

and external stakeholders may use it to 

understand the operation of the 

demonstration. The financial 

information collection is used in our 

financial statements and shared with the 

auditors who validate CMS’ financial 

position. The Money Follows the Person 

Rebalancing Demonstration (MFP) 

Finders File, MFP Program Participation 

Data file, and MFP Services File are 

used by the national evaluation 

contractor to assess program outcomes 

while we use the information to monitor 

program implementation. The MFP 

Quality of Life data is used by the 

national evaluation contractor to assess 

program outcomes. The evaluation is 

used to determine how participants’ 

quality of life changes after transitioning 

to the community. The semi-annual 

progress report is used by the national 

evaluation contractor and CMS to 

monitor program implementation at the 

grantee level. Form Number: CMS– 

10249 (OMB control number: 0938– 

1053); Frequency: Yearly, quarterly, and 

semi-annually; Affected Public: State, 

Local, or Tribal Governments; Number 

of Respondents: 41; Total Annual 

Responses: 410; Total Annual Hours: 

4,326. (For policy questions regarding 

this collection contact Alicia Ryce at 

410–786–1075.) 

William N. Parham, III, 

Director, Division of Information Collections 

and Regulatory Impacts, Office of Strategic 

Operations and Regulatory Affairs. 

[FR Doc. 2024–03476 Filed 2–20–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

Administration on Disabilities, The 

President’s Committee for People With 

Intellectual Disabilities 

AGENCY: Administration for Community 

Living, HHS. 

ACTION: Notice. 

SUMMARY: The President’s Committee 

for People with Intellectual Disabilities 

(PCPID) will host a virtual meeting for 

its members to address issues 

surrounding Home and Community 

Based Services (HCBS) to be examined 

in the Committee’s Report to the 

President. All the PCPID meetings, in 

any format, are open to the public. This 

virtual meeting will be conducted in a 

discussion format with committee 

members addressing the issues and 

recommendations identified by PCPID 

workgroups proposing to be 

incorporated in the PCPID Report to the 

President. 

DATES: The meeting will take place 

virtually on March 21, 2024 from 12:00 

p.m. to 5:00 p.m. (EST). 

Comments received by March 12, 

2024 will be shared with the PCPID at 

the March 21, 2024 meeting. 

ADDRESSES: 

Comments: Comments and 

suggestions may be shared through the 

following ACL.gov link: https://acl.gov/ 

form/pcpid. 

Webinar/Conference Call: The virtual 

meeting is scheduled for Thursday, 

March 21, 2024 from 12:00 p.m. to 5:00 

p.m. (EST) and may end early if 

discussions are finished. The meeting is 

open to the public and will be held 

through a zoom meeting platform. In 

order to observe the proceedings, you 

must register in advance of the meeting 

at the following link: https://

www.zoomgov.com/webinar/register/ 

WN_HnpxBCCsSUGJv6SX_O_YlQ. 

FOR FURTHER INFORMATION CONTACT: Mr. 

David Jones, Director, Office of 

Intellectual Developmental Disabilities, 

330 C Street SW, Switzer Building, 

Room 1126, Washington, DC 20201. 

Telephone: 202–795–7367. Fax: 202– 

795–7334. Email: David.Jones@

acl.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Agenda: The Committee will 

collectively discuss the HCBS issues 

and recommendations identified by four 

PCPID workgroups as it relates to the 

areas of direct support professionals, 

employment, community living, and 

Federal support programs. This 

discussion will help develop a 

framework for the preparation of the 

PCPID Report to the President. 

Comments: Stakeholder input is very 

important to the PCPID. Comments and 

suggestions especially from people with 

intellectual disabilities, are welcomed. 

If there are comments related to HCBS 

or other areas that you would like to 

inform the PCPID, please share them 

through the following ACL.gov link: 

https://acl.gov/form/pcpid. 

Background Information on the 

Committee: The PCPID acts in an 

advisory capacity to the President and 

the Secretary of Health and Human 

Services on a broad range of topics 

relating to programs, services and 

support for individuals with intellectual 

disabilities. The function of PCPID is to: 

(1) provide such advice concerning 

intellectual disabilities as the President 

or the Secretary of Health and Human 

Services may request; and (2) provide 

advice to the President and the 

Secretary of Health and Human Services 

to promote full participation of people 

with intellectual disabilities in their 

communities, such as: (A) expanding 

educational opportunities; (B) 

promoting housing opportunities; (C) 

expanding opportunities for competitive 

integrated employment; (D) improving 

accessible transportation options; (E) 

protecting rights and preventing abuse; 

and (F) increasing access to assistive 

and universally designed technologies; 

and (3) provide advice to the President 

and the Secretary of Health and Human 

Services to help advance racial equity 

and support for people with intellectual 

disabilities within underserved 

communities. 

Statutory Authority: E.O. 14048, 85 

FR 57313. 

Dated: February 14, 2024. 

Jill Jacobs, 

Commissioner, Administration on 

Disabilities. 

[FR Doc. 2024–03458 Filed 2–20–24; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Clinical Center; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Board of Scientific 

Counselors of the NIH Clinical Center. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended, 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

Clinical Center, including consideration 

of personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors of the NIH Clinical Center. 

Date: March 25, 2024. 

Time: 11:00 a.m. to 5:00 p.m. 


khammond on DSKJM1Z7X2PROD with NOTICES
13088 Federal Register / Vol. 89, No. 35 / Wednesday, February 21, 2024 / Notices 

Agenda: To review and evaluate the 

Pediatrics and Critical Care Medicine 

Department, Emerging Pathogens Section. 

Place: Clinical Center, 10 Center Drive, 

Bethesda, MD 20892 (Virtual). 

Name of Committee: Board of Scientific 

Counselors of the NIH Clinical Center. 

Date: March 26, 2024. 

Time: 11:00 a.m. to 12:30 p.m. 

Agenda: To review and evaluate the 

Pediatrics and Critical Care Medicine 

Department, Emerging Pathogens Section. 

Place: Clinical Center, 10 Center Drive, 

Bethesda, MD 20892 (Virtual). 

Contact Person: Ronald Neumann, M.D., 

Deputy Scientific Director, Clinical Center, 

National Institutes of Health, 10 Center Drive, 

Bethesda, MD 20892, 301–496–6455, 

rneumann@cc.nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Patricia B. Hansberger, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–03441 Filed 2–20–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel; Center for Inherited Disease Research 

(CIDR). 

Date: March 7, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Rudy O. Pozzatti, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, 6700B Rockledge Drive, MSC 6908, 

Rockville, MD 20892, (301) 402–8739, 

pozzattr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: February 15, 2024. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–03520 Filed 2–20–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Preteen Suicide Prevention. 

Date: March 19, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Contact Person: Evon Abisaid, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

Rockville, MD 20852, (301) 827–0399, 

ereifejes@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Precision HIV Health: Integrating Data and 

Implementation Science. 

Date: March 20, 2024. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Contact Person: Jasenka Borzan, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, Neuroscience Center, 6001 

Executive Blvd., Bethesda, MD 20892, 301– 

435–1260, jasenka.borzan@nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Pathway to Independence Awards (K99/R00). 

Date: March 22, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Contact Person: David W. Miller, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

Neuroscience Center, 6001 Executive Blvd., 

Bethesda, MD 20892–9608, 301–443–9734, 

millerda@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: February 15, 2024. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–03522 Filed 2–20–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; Review of NIH Pathway to 

Independence Award (K99/R00) 

Applications. 

Date: March 11–12, 2024. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute of General Medical 

Sciences, Natcher Building, 45 Center Drive, 

Bethesda, Maryland 20892 (Virtual Meeting). 

Contact Person: Lee Warren Slice, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 


khammond on DSKJM1Z7X2PROD with NOTICES